APSD of Nasal Products

Nasal drug products typically produce droplets larger than 10-20 microns, to ensure nasal deposition and minimise deposition within the lungs. However, a proportion of fine droplets in the <10 micron range may also be produced. Deposition of this respirable fraction beyond the nasal tract may be undesirable and must be quantified. Aerodynamic particle sizing with a cascade impactor is a US FDA requirement and is recommended in USP <601> to assess potential deposition beyond the nasal cavity.

Our nasal product testing solutions enable better, more informative testing in line with evolving market requirements.

Like nasal sprays, nasal aerosols also typically produce droplets in the range 20-200 microns, which is outside the effective range of cascade impactors. However, most aerosols typically deliver a proportion (typically <5%) of fine droplets in the <10 micron range, which must be quantified.

Used together with a cascade impactor such as the Andersen Cascade Impactor (ACI) and a high volume expansion chamber, such as the Glass Expansion Chamber, the Vertus® III/Vertus® III+ automated shake, fire and flow control systems can be used to meet the need for highly consistent nasal aerosol actuation as recommended by USP <601>.

Shot weight measurement

The Vertus® III+ model includes an integrated analytical balance for automated nasal spray shot weight measurement.

Nasal Aerosols: Semi-Automated APSD Measurement

The Vertus® III automated shake, fire and flow range is made up of integrated turn-key solutions for precise, controlled and reproducible nasal spray testing. Compatible with most nasal aerosols, the Vertus III or Vertus III+ offers analysts complete control over:

  • The speed, angle and duration of shaking, ahead of actuation
  • Firing force and the speed of application and release of that force
  • The time delay between the end of shaking and device actuation

View the Vertus® III Range

How Does a Cascade Impactor Work?

Play Video

Manual Nasal Aerosol Sampling

In addition to the Vertus® automated shake, fire and flow systems, we offer a full suite of products to support manual testing, including flow meters, flow controllers and vacuum pumps.

View the manual system

Related Applications

We also offer a range of equipment for additional nasal aerosol testing application support:

Semi-Automation Tools

Improve efficiency
Reduce variability
Eliminate handling error
Increase testing capacity

Related Services

Related News & Resources

New IPAC-RS paper offers insight and guidance for testing aqueous nasal inhalation products

2nd November 2023

Find out more

Copley introduces the new Flow Rate Sensor, a dedicated device for inhaler testing systems.

27th June 2023

Find out more

Introducing the Copley Impactor Genie™ IG 200i, a two-in-one solution for quicker, more efficient inhaled product testing

25th April 2023

Find out more

Copley launches EnviroMate™, an efficient, benchtop environmental chamber for inhaler testing

14th September 2022

Find out more

Copley Scientific joins the Industries Forum of the Taskforce for Lung Health

22nd June 2021

Find out more

Introducing Inhalytix®: a new solution for analysing and managing inhaler test data from Copley

18th March 2021

Find out more

Copley introduces a comprehensive range for nasal product testing

11th March 2021

Find out more

Nasal Product Testing Brochure 2023

View download

Perfect Timing for the Automation of OINDP Testing

View download

Understanding the Links Between Drug Delivery Route and In Vitro Test Methods

View download

Nasal Drug Product Development

View download

Reducing Inhaler Testing Variability Through Test Environment Control

View download

Improving In Vitro Test Methods for Nasal Drug Products

View download

Refining Test Methods for a New Generation of Nasal Drug Products

View download

Semi-Automating Inhaler Testing – A Good Idea, but Where to Start?

View download

A short Q&A with our CEO, Mark Copley, On Inhaled Product Testing

View download